○Sakura Ishikawa1,2, Keisuke Nakase1, Juri Koizumi1, Yuji Hirai2, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.,, 2. Dept. Infectious Disease, Tokyo Univ. Hachioji Medical center.)
Session information
Poster Presentation
(C) Pharmaceutical Biology
[28P1-am1] Antibacterial and antiviral agents/Drug resistance
Tue. Mar 28, 2023 9:00 AM - 10:40 AM [Room P1] Gymnasium (1F)
○Hana Kobayashi1, Hiroshi Kaneko1, Aiko Toguchi1, Yuka Yanagi1, Shogo Otake1, Hidemasa Nakaminami1 (1. Sch.Pharm.,Tokyo Univ.Pharm.Life Sci.f)
○Taiga Natori1, Takuma Yoshida1, Takemi Ozeki1, Rika Watanabe1, Hidetoshi Masuda1, Rika Sawara1, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)
○Aiko Toguchi1, Hiroshi Kaneko1, Shiho Yokomori1, Toshiko Miyata2, Takao Fujimura3, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Saitama Citizens Med. Ctr., 3. Grad. Sch. Med. Sci., Kitasato Univ.)
○Yuji Miyazaki1, Juri Koizumi1, Keisuke Nakase1, Yu Sasaki2,3, Nobukazu Hayashi3, Hidemasa Nakaminami1 (1. Tokyo Univ. Pharm. Life Sci.,, 2. Shinmatsudo Central General Hospital, 3. Toranomon Hospital)
○Ken-ichi Tokioka1, Yoshihiro Inoue2, Yasuko Kurashige1, Kaoru Hasebe3, Yasumasa Shimizu1 (1. Dept. of Pharm., Ebina General Hosp., 2. Showa Pharm. Univ., 3. Dept. of Clin. Lab., Ebina General Hosp.)
○Midori Iida1, Yuka Motomura1, Rie Mukai1, Parinya Wilai1, Daisuke Sakamoto1, Mitsuhiro Kamada2, Daiki Hagiwara3, Tomomitsu Satho1, Motoyasu Miyazaki4, Tohru Takata5, Nobuhiro Kashige1 (1. Faculty ofPharmaceutical Sciences Fukuoka University., 2. Department of Pharmacy, Fukuoka University Hospital., 3. Department of Pharmacy, Fukuoka University Nishijin Hospital., 4. Department of Pharmacy, Fukuoka University Chikushi Hospital., 5. Department of Infection Control, Fukuoka University Hospital.)
○Harue Nomura1, Mayuna Yamashita1, Azumi Itakura1, Katsuya Sakuma2, Yasunori Isshiki1 (1. Fac. Pharm. Sci., Josai Univ., 2. Ogawa & Co.,Ltd.)
○Ruri Ota1, Takeaki Wajima1, Emi Tanaka1,2, Kei-ichi Uchiya1 (1. Fac. Pharm., Meijo Univ., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)
○Sonoe Hirano1, Takeaki Wajima1, Emi Tanaka1,2, Shoji Seyama3, Kei-ichi Uchiya1 (1. Fac. Pharm., Meijo Univ., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 3. Keio Univ. Hosp.)
○Rio Nakagawa1, Takeaki Wajima1, Emi Tanaka1,2, Chihiro Ito1, Uchiya Kei-ichi1 (1. Fac. Pharm., Meijo Univ., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci)
○Ayami Mezaki1, Yuji Morita1 (1. Meiji Pharmaceutical Univ.)
○Miu Furukawa1, Ayaka Matsuda1, Ryunosuke Taii1, Yuji Morita1 (1. Meiji Pharmaceutial Univ.)
○Naotsugu Fujimoto1, Emiko Mizusawa1, Ryunosuke Taii1, Yuji Morita1 (1. Meiji Pharm. Univ.)
○Emiko Mizusawa1, Yuji Morita1 (1. Meiji Pharmaceutical Univ.)
○Mizuki Sugano1, Yoshiaki Sakairi1, Takahiro Nagumo1, Kunihiko Nishino2,3, Yuji Morita1 (1. Meiji Pharmaceutical Univ., 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. SANKEN, Osaka Univ.)
○Ruri Nojima1, Anne Ohnishi1, Ryosuke Iwasaki2, Yoshiaki Kawamura2, Yuji Morita1 (1. Meiji Pharmaceutical Univ., 2. Sch. Pharm., Aichi-Gakuin Univ.)
○Kota Hayashi1, Yoshiaki Sakairi1, Haruka Kumada1, Yuji Morita1 (1. Meiji Pharmaceutical Univ.)
Moyu Tanishige1, Riho Yasuoka1, Yuma Kondo2, Koshiro Hyakutome1, Daichi Morita1,2, Wakano Ogawa3, Takanori Kumagai1,2, ○Teruo Kuroda1,2 (1. Fac. Pharm. Sci., Hiroshima Univ., 2. Grad. Sch. Biomed. Heal. Sci., Hiroshima Univ., 3. Daiichi Univ. Pharm.)
○Noriteru Yamada1, Go Kamoshida1, Daiki Yamaguchi1, Momoko Matsuoka1, Tomoka Nakamura1, Reika Yamauchi1, Masahiro Fujimuro1, Kinnosuke Yahiro1 (1. Kyoto Pharmaceutical University)
○Takemasa Takii1,2, Masato Iwatsuki3, Tomuyuki Yamaguchi4, Aoi Kimushima3, Yoshiyuki Watanabe3, Masaaki Nakayama4, Naoya Ohara4, Yukihiro Asami3 (1. Res. Insti. Tubercu., Japan Anti-Tubercu. Associ., 2. Grad. Sch. Pharm. Sci., Nagoya City Univ., 3. Memori. Insti. Omura, Kitazato Univ., 4. Grad. Sch. Med. Denti. Pharm. Sci., Okayama Univ. )
○Masahiko Miyamoto1, Rira Kaneko1, Takumi Sato1, Yusuke Chihara1, Koki Tsuchida1, Kae Tsuruya1, Moe Nakano1 (1. Pharm., Niigata Univ. Pharm. Med. Life Sci.)
○kazuya mori1, Etienne Kochole Obossou1, Rikako Kusunose1, Yasuo Shikamoto1, Sakakibara Iwao1 (1. Yokohama Univ. Pharm.)
○Hirotaka Sato1, Jun-na Fukui2, Hiroyuki Hirano3, Yutaka Arimura2, Hiroyuki Osada3,4, Michiaki Masuda1, Yoko Aida5 (1. Sch. Med. DMU., 2. Fac. Appl. Life Sci. NVLU., 3. RIKEN CSRS, 4. Dpt. Pharm Sci. Univ. Shizuoka, 5. Grad. Sch. Agr. Univ. Tokyo)
○Takashi Emi1, Yong jin Chang1, Takumi Watanabe2,4, Jyunichi Ito3, Kyoko Hayashi4, Toshio Kawahara4 (1. Yaegaki Biotech., 2. Bio-Lab, 3. Cent. Jpn. Inter. Airport, 4. chubu Univ.)
○Masayo Ogawa1, Shinako Suzuki1, Yukari Ishida1, Miki Umeda2, Masaya Takemoto1, Tohru Daikoku1 (1. Pharm., Hokuriku Univ, 2. Grad. Sch. Med., Nagoya Univ)
○Motohiko Ogawa1, Mana Murae2,3, Tomoharu Mizukami2, Ryutaro Gemba2,4, Takuya Irie2,3, Masayuki Shimojima1, Hideki Ebihara1, Koji Noguchi3, Masayoshi Fukasawa2 (1. Dept Virol.1, NIID, 2. Dept Biochem. and Cell Biol., NIID, 3. Fac Pharma. Sci., Tokyo Univ. of Sci., 4. Fac Sci., Tokyo Univ. of Sci.)
○Hirotomo Kadoya1, Akira Tanaka1, Zyun Kawase1, Masahiro Yoshida2, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical University, 2. Tokushima Bunri University)
○Ryohto Koharazawa1, Mayu Hayakawa2, Kotone Miyazaki2, Yoshihisa Hirota1, Yoshitomo Suhara1 (1. Grad. Engineering and Science, Shibaura Institute of Technology, 2. College of Systems Engineering and Science, Shibaura Institute of Technology)